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Muhammad Rashid Siddique1, Steve Shynder1, Muhammad Aqeel Ashraf2*, Ismail Yusoff3 and Abdul Wajid4Retraction
This article is retracted.
The data in this article [1] was used without permis-
sion by the lead author Muhammad Rashid Siddique.
The lead author accepts full responsibility and would
like to apologize to the owners of the data (Dr Steve
Shnyder, University of Bradford, UK), as well as the
co-authors of this article, the Editors and readers.
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